Enbiya AKSAKAL, Kamuran KALKAN, Serdar SEVİMLİ, Oktay GÜLCÜ, Uğur AKSU, Arzu KALAYCI KARABAY, İbrahim Halil TANBOĞA, Selim TOPCU

Aortic valve sclerosis is associated with the extent of coronary artery disease in stable coronary artery disease

Background/aim: Aortic valve sclerosis (AVS) is characterized by lipid deposition and calcific infiltration on the edge of aortic leaflets without significant restriction of motion. The SYNTAX Score (SS) is an important method for evaluating coronary artery disease (CAD). Many studies showed that there is an important relation between the SS and undesired cardiac outcomes. In our study, we investigated the correlation between the SS and AVS by including both ACS and stable CAD cases. Materials and methods: We enrolled 543 patients with CAD who underwent coronary angiography into this cross-sectional study between September 2013 and September 2014. Results: The study population was divided into two groups according to SS values above and below 22. Diabetes mellitus (DM) incidence was greater in the group with high SS values (26.3% vs. 19.2%, P = 0.052.). Left ventricular ejection fraction (LVEF) and glomerular filtration rate were lower. Low-density lipoprotein cholesterol and triglyceride levels were lower while platelet counts were higher. In multivariate analysis, for the stable coronary artery group AVS existence, platelet count, LVEF value, and chronic obstructive pulmonary disease were found as independent predictors. Conclusion: Our study results demonstrated that AVS is significantly associated with the complexity of CAD, especially in patients with stable CAD. This study provides new information regarding the role of AVS in CAD complexity.

PDF

___

1. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, OBrien KD. Characterization of the early lesion of degenerative valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90: 844-853.
2. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. New Engl J Med 1999; 341: 142-147.
3. Kaden JJ, Dempfle CE, Grobholz R, Tran HT, Kilic R, Sarikoc A, Brueckmann M, Vahl C, Hagl S, Haase KK et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 2003; 170: 205-211.
4. Otto CM. Why is aortic sclerosis associated with adverse clinical outcomes? J Am Coll Cardiol 2004; 43: 176-178.
5. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111: 3316-3326.
6. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-227.
7. Coffey S, Cox B, Williams MJ. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol 2014; 63: 2852-2861.
8. Head SJ, Farooq V, Serruys PW, Kappetein AP. The SYNTAX score and its clinical implications. Heart 2014; 100: 169-177.
9. Korkmaz L, Pelit E, Bektas H, Agac MT, Erkan H, Gurbak I, Çelik Ş. Aortic valve sclerosis in acute coronary syndrome patients : potential value in predicting coronary artery lesion complexity. Herz 2014; 39: 1001-1004.
10. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2015; 37: 267-315.
11. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-619.
12. Milin AC, Vorobiof G, Aksoy O, Ardehali R. Insights into aortic sclerosis and its relationship with coronary artery disease. J Am Heart Assoc 2014; 3: e001111.
13. Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E. Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003; 41: 136-141.
14. Mazzone A, Venneri L, Berti S. Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links. J Cardiovasc Med. 2007; 8: 983-989.
15. Rossi A, Gaibazzi N, Dandale R, Agricola E, Moreo A, Berlinghieri N, Sartorio D, Loffi M, De Chiara B, Rigo F et al. Aortic valve sclerosis as a marker of coronary artery atherosclerosis; a multicenter study of a large population with a low prevalence of coronary artery disease. Int J Cardiol 2014; 172: 364-367.
16. Chakrabarti AK, Gibson CM. The SYNTAX score: usefulness, limitations, and future directions. J Invasive Cardiol 2011; 23: 511-512.
17. Farooq V, Head SJ, Kappetein AP, Serruys PW. Widening clinical applications of the SYNTAX Score. Heart 2014; 100: 276- 287.
18. Bhatt H, Sanghani D, Julliard K, Fernaine G. Does aortic valve sclerosis predicts the severity and complexity of coronary artery disease? Indian Heart J 2015; 67: 239-244.
19. Korkmaz L, Erkan H, Agac MT, Pelit E, Bektas H, Acar Z, Gurbak I, Kara F, Çelik Ş. Link between aortic valve sclerosis and myocardial no-reflow in ST-segment elevation myocardial infarction. Herz 2015; 40: 502-506.